| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2217/FCA.10.11 |
| P698 | PubMed publication ID | 20462344 |
| P50 | author | Arthur Wilde | Q88314138 |
| P2093 | author name string | Nynke Hofman | |
| Laura T van Lochem | |||
| P2860 | cites work | MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia | Q22009462 |
| Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death | Q24294267 | ||
| Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3 | Q24295202 | ||
| Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak | Q24296910 | ||
| A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene | Q24297875 | ||
| Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias | Q24298971 | ||
| Mutation of an A-kinase-anchoring protein causes long-QT syndrome | Q24304235 | ||
| Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex | Q24308697 | ||
| Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome | Q24308735 | ||
| SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome | Q24314276 | ||
| Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes | Q24315860 | ||
| Mutations in the hminK gene cause long QT syndrome and suppress IKs function | Q24323571 | ||
| Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations | Q24529526 | ||
| Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org) | Q24654954 | ||
| Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome | Q24655604 | ||
| Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death | Q24675134 | ||
| Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism | Q28117072 | ||
| Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia | Q28142708 | ||
| Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 | Q28145423 | ||
| Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia | Q28201561 | ||
| A sodium-channel mutation causes isolated cardiac conduction disease | Q28203120 | ||
| A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel | Q28204838 | ||
| Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A) | Q28206505 | ||
| Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia | Q28235110 | ||
| Inherited conduction system abnormalities--one group of diseases, many genes | Q28236888 | ||
| Genetic basis and molecular mechanism for idiopathic ventricular fibrillation | Q28265902 | ||
| Catecholaminergic polymorphic ventricular tachycardia | Q28287523 | ||
| SCN5A is expressed in human jejunal circular smooth muscle cells | Q30858816 | ||
| Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. | Q33146000 | ||
| Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. | Q33146452 | ||
| Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family | Q33147123 | ||
| Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. | Q33147854 | ||
| Proposed diagnostic criteria for the Brugada syndrome: consensus report | Q33148286 | ||
| Short QT syndrome. Genotype-phenotype correlations | Q33153179 | ||
| Short QT syndrome: clinical findings and diagnostic-therapeutic implications | Q33154179 | ||
| [Short QT syndrome]. | Q33155122 | ||
| Clinical and molecular genetics of the short QT syndrome | Q33156151 | ||
| Sudden cardiac arrest associated with early repolarization | Q33156255 | ||
| The long QT syndrome. Prospective longitudinal study of 328 families | Q33156679 | ||
| Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy | Q33156860 | ||
| Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond | Q33156900 | ||
| SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome | Q33158197 | ||
| The long QT syndrome: a prospective international study | Q33168684 | ||
| Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients | Q33173888 | ||
| A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype | Q33572315 | ||
| Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome | Q33772836 | ||
| Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel | Q34015485 | ||
| Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome | Q34232976 | ||
| Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death | Q34241382 | ||
| ETIOLOGY AND PATHOLOGY OF BILATERAL BUNDLE BRANCH BLOCK IN RELATION TO COMPLETE HEART BLOCK. | Q34257001 | ||
| Sudden death associated with short-QT syndrome linked to mutations in HERG. | Q34283788 | ||
| Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. | Q34385271 | ||
| Ankyrins and human disease: what the electrophysiologist should know | Q34541948 | ||
| Management and treatment of Andersen-Tawil syndrome (ATS). | Q34613764 | ||
| Brugada syndrome: from cell to bedside | Q34667046 | ||
| The QT syndromes: long and short | Q34818456 | ||
| J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance | Q34858254 | ||
| Impact of ancillary subunits on ventricular repolarization | Q36248808 | ||
| Genetics of cardiac arrhythmias | Q36257367 | ||
| Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation | Q36628071 | ||
| Bidirectional tachycardia in a child. A study using His bundle electrography | Q36822217 | ||
| Sudden cardiac death: epidemiology, mechanisms, and therapy | Q36920968 | ||
| Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy | Q37100287 | ||
| Haplotype-sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation | Q37156064 | ||
| Short QT syndrome. Update on a recent entity | Q37342308 | ||
| The risk of cardiac events and genotype-based management of LQTS patients. | Q37370872 | ||
| Prevalence of the congenital long-QT syndrome. | Q37442080 | ||
| The molecular genetics of arrhythmias and sudden death | Q40846746 | ||
| In vivo human demonstration of phase 2 reentry | Q42418639 | ||
| Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. | Q43073409 | ||
| The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome | Q43074306 | ||
| Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch. | Q43214630 | ||
| Update on genetic analysis in Brugada syndrome | Q43736095 | ||
| Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction | Q46843968 | ||
| Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response | Q46988579 | ||
| Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease | Q47207106 | ||
| Mutation in the KCNQ1 gene leading to the short QT-interval syndrome | Q47438291 | ||
| Molecular basis of the long-QT syndrome associated with deafness | Q48049583 | ||
| Short QT syndrome: Should we push the frontier forward? | Q51348442 | ||
| Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. | Q51955831 | ||
| Task Force on Sudden Cardiac Death of the European Society of Cardiology. | Q52057914 | ||
| A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22 | Q55843608 | ||
| Congenital long QT syndrome | Q58010712 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Ventricular Fibrillation | Q848662 |
| P304 | page(s) | 395-408 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Future Cardiology | Q15765184 |
| P1476 | title | Genetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart | |
| P478 | volume | 6 |
| Q57626635 | EHRA/HRS/APHRS expert consensus on ventricular arrhythmias |
| Q57626770 | EHRA/HRS/APHRS expert consensus on ventricular arrhythmias |
| Q38013733 | In vitro uses of human pluripotent stem cell-derived cardiomyocytes. |
| Q53132740 | Neonatal ventricular fibrillation and an elusive ALCAPA: things are not always as they seem. |
Search more.